Abstract
Background and Objectives The transition to menopause is commonly associated with disappearance of menstrual cycle symptoms and emergence of vasomotor symptoms. Although menopausal women report a variety of mood, digestive, and pain symptoms, it remains unclear what symptoms emerge prior to menopause, if symptoms occur in predictable clusters, how these clusters change from across the premenopause-perimenopause-menopause transition, or if distinct phenotypes are present within each life stage.
Methods We present analysis of self-reported symptom presentation in premenopausal to menopausal women using the MenoLife app, which includes 4,789 (n=1,115(23%) premenopausal, n=1,388(29%) perimenopausal, n=2,286(48%) menopausal) individuals and 147,501 (n=27,371(19%) premenopausal, n=57,964(39%) perimenopausal, n=61,806(42%) menopausal) symptom logs. Clusters generated from logs of 45 different symptoms were assessed for similarities across methods: hierarchical clustering analysis (HCA), K-Means clustering of principal components of symptom reporting, and binomial network analysis. Participants were further evaluated based on menstrual cycle regularity or type of menopause.
Results Menstrual cycle-associated symptoms (e.g., cramps, breast swelling), digestive, mood, and integumentary symptoms were characteristic of premenopausal women. Vasomotor symptoms, pain, mood, and cognitive symptoms were characteristic of menopause. Perimenopausal women exhibited both menstrual cycle-associated and vasomotor symptoms. Subpopulations across life stages presented with additional correlated mood and cognitive symptoms, integumentary complaints, digestive, nervous, or sexual symptoms. Symptoms also differed among women depending on the reported regularity of their menstrual cycles or the way in which they entered menopause. Notably, we identified a set of symptoms that were very common across life stages: fatigue, headache, anxiety, and brain fog. We consistently identified the lack of predictive power of hot flashes for other symptoms except night sweats.
Conclusions Together, premenopausal women exhibit menstrual cycle-associated symptoms and menopausal women reported vasomotor symptoms, perimenopausal women report both; and all report high rates of fatigue, headache, anxiety, and brain fog. Limiting focus of menopausal treatment to vasomotor symptoms, or to premenstrual syndrome in premenopausal women, neglects a large proportion of overall symptom burden. Future research and interventions targeting mood and cognitive, digestive, and integumentary symptoms are needed across stages of female reproductive life.
Competing Interest Statement
This work was supported in part with research funding from Amyris, INC provided to Opensci, LLC. JPK and SGA are founding partners of Opensci, LLC. ADG reports no conflicts of interest. Amyris played no role in study design, data collection, analysis and interpretation of data, or the writing of this manuscript. Amyris did not have the opportunity to review this manuscript prior to its submission for peer review.
Funding Statement
This work was supported in part with research funding from Amyris, INC provided to Opensci, LLC. JPK and SGA are founding partners of Opensci, LLC. No other funding supported this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures have been approved by Western Institutional Review Board-Copernicus Group (registration number, OHRP and FDA, IRB0000053; parent organization number, IORG0000432) Study Number: 1284093.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
